Sunscreens Inadequately Protect Against Ultraviolet-A-Induced Free Radicals in Skin: Implications for Skin Aging and Melanoma?  by Haywood, Rachel et al.
ORIGINAL ARTICLE
Sunscreens Inadequately Protect Against Ultraviolet-A-Induced
Free Radicals in Skin: Implications for Skin Aging and
Melanoma?
Rachel Haywood, PeterWardman, Roy Sanders, and Claire Linge
RAFT Institute of Plastic Surgery, Mount Vernon Hospital, Northwood, Middlesex, UK; and Gray Cancer Institute, Mount Vernon Hospital,
Northwood, Middlesex, UK
Sunscreens are employed to mitigate the adverse e¡ects
of sunlight on skin but are primarily designed to pre-
vent ultraviolet-B-associated burning and damage. The
increasingly recognized role of ultraviolet A in aging,
and possibly melanoma, highlights the need to include
ultraviolet A screens; however, validation remains di⁄-
cult.We have used a novel method to establish the e⁄-
cacy of sunscreens, by measuring ultraviolet-A-induced
free-radical production (thought to contribute towards
ultraviolet-A-related aging and malignant change).
Electron spin resonance spectroscopy was used to detect
free radicals directly in human Caucasian skin during
irradiation with levels of ultraviolet comparable to solar
intensities. Using this system the protection a¡orded by
three high factor sunscreens (sun protection factor
20þ ) that claim ultraviolet A protection was examined.
Each sunscreen behaved similarly: at recommended
application levels (X2 mg per cm2) the ultraviolet-in-
duced free radicals were reduced by only about 55%,
and by about 45% at 0.5^1.5 mg per cm2 (0.5 mg per
cm2 reported for common usage). A ‘‘free-radical pro-
tection factor’’ calculated on the basis of these results
was only 2 at the recommended application level,
which contrasts strongly with the erythema-based sun
protection factors (mainly indicative of ultraviolet B
protection) quoted by the manufacturers (20þ ). The
disparity between these protection factors suggests that
prolonged sunbathing (encouraged by use of these
creams) would disproportionately increase exposure to
ultraviolet A and consequently the risk of ultraviolet-
A-related skin damage. Key words: electron spin resonance
spectroscopy/free radicals/photoaging of skin/sunlight/sun-
screens. J Invest Dermatol 121:862 ^868, 2003
I
t is clearly established that ultraviolet (UV) wavelengths of
sunlight are carcinogenic, contributing towards the forma-
tion of skin malignancy in the form of squamous and basal
cell carcinoma and melanoma. There is a general consensus
that basal and squamous cell carcinomas are predominantly
a result of direct damage to the DNA by interaction with UVB
(solar wavelengths 280^320 nm) (Linge, 1996). Epidemiologic
data links melanoma to intense sunlight exposure in childhood,
and provides support for a role of UVA (Moan et al, 1999).
Although there is agreement that UV radiation is the cause, how-
ever, the precise wavelengths and mechanisms involved are not
clear. Setlow et al (1993) showed the induction of melanoma in
the ¢sh model Xiphophorus by UVA, UVB, and blue-visible wave-
lengths; Ley (1997) demonstrated equal e¡ectiveness of UVA and
UVB in inducing melanocytic hyperplasia in the opossum Mono-
delphis domestica; and Noonan et al (2001, 2003), using combined
UVB and UVA wavelengths (ratio 2:1), recently demonstrated
the induction of melanoma in a transgenic neonatal mouse
model. Berking et al (2001) showed that UVB in combination
with basic ¢broblast growth factor could transform human mel-
anocytes. The role of UVA in human melanoma is still inconclu-
sive (Wang et al, 2001).
Whereas UVB is believed to interact directly with DNA to in-
itiate signature mutations of basal and squamous cell carcinomas,
UVA wavelengths (320^400 nm) are believed to interact indir-
ectly, inducing the production of free radicals (Packer, 1994;
Scharfettner-Kochanek et al, 1997). Free radicals may indirectly
damage DNA and cause protein damage, which contributes to
premature aging, or photoaging. UVA-induced p53 production
and DNA damage (Burren et al, 1998), genomic instability (Phil-
lipson et al, 2002), and immunosuppression (Dumay et al, 2001)
have been demonstrated. Fas expression has also been shown to
result from UVA as well as UVB (Bang et al, 2002).
Despite the extensive use of sunscreens during the last two de-
cades, the incidence of skin cancers is still increasing, and the role
of sunscreens in protecting against skin cancers is controversial.
Sunscreen use has been shown to decrease the formation of actinic
keratoses, which are linked to squamous cell carcinomas (Thomp-
son et al, 1993; Naylor et al, 1995). Animal models have shown that
sunscreens reduce the incidence of basal and squamous cell tumors
(Sekura Snyder and May, 1975; Kligman et al, 1980; Forbes et al,
1989; Reeve et al, 1990), which are UVB related; however, there
have been several studies to suggest that sunscreen use is associated
with increased risk of melanoma (Autier et al, 1995; Azizi et al,
2000; Vainio and Bianchini, 2000). This may re£ect inadequate
sunscreen application (Stokes and Di¡ey, 1997; Wulf et al, 1997;
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Gaughan and Padilla, 1998); lack of durability of the application;
the lack of, or inadequacy of, UVA ¢lters in sunscreen preparations
combined with prolonged sunbathing (Autier et al, 1995); the
photo-instability of sunscreen ¢lters that results in reduced protec-
tion; or the production of reactive free radicals or mutagens within
the cream (Flindt-Hanse et al, 1988; Shaw et al, 1992; Gasparro, 1993;
Knowland et al, 1993; Dunford et al, 1997). A link between sun-
screen use and melanoma, however, is still debated (Huncharek
and Kupelnick, 2002; Rigel, 2002) and unclear (Bigby, 1999).
The sun protection factor (SPF) of sunscreens is an interna-
tionally accepted standard by which the e⁄cacy of sunscreens is
assessed: it is based solely on prevention of erythema (sunburn),
which is principally induced by UVB (Cole, 2001), and it
is erythema (a downstream in£ammatory response to the direct
damage itself) that is the criterion by which people usually limit
their sun exposure (Autier et al, 1999).Whereas SPF may indicate
protection against UVB-induced carcinogenesis, it cannot be
used as an indicator of the ‘‘indirect’’ damage resulting from
UVA exposure, as erythema is predominantly a response to UVB.
As skin carcinogenesis is highly complex, the use of a range of
markers for damage in skin itself is likely to be necessary to com-
plement SPF (an indicator of UVB protection) for use in evalua-
tion of total skin cancer risk. Other studies have been published
that assess ‘‘direct’’ DNA damage, p53 formation, and protection
against UV-induced immunosuppression (Freeman et al, 1988;
Ley and Fourtanier, 1997; Ananthaswamy et al, 1998; Burren et al,
1998; Bykov et al, 1998). There are several methods to measure the
protection a¡orded by sunscreens against UVA damage to skin
(reviewed by Lim et al, 2001); however, these methods are not va-
lidated (Cole, 2001). The protection against free radicals induced
by UVA, to date, has not been measured.
In this study we have adapted an electron spin resonance
(ESR) method to measure UV-induced free-radical production
in human skin, and assessed the protection against free-radical
production provided by commercial sunscreens. The free radicals
formed upon UV irradiation of skin (and that are associated with
DNA and protein damage) are not usually directly detectable at
room temperature. An exception to this, however, is the ascorbate
radical, which is formed when ascorbate (vitamin C ^ a cellular
antioxidant) reacts with free radicals.The ascorbate radical is read-
ily detected using ESR spectroscopy in skin biopsies exposed to
UV irradiation (Jurkiewicz and Buettner, 1996) and is accepted as
a reliable marker for cellular free-radical production and oxidative
stress (Buettner and Jurkiewicz, 1995; Jurkiewicz and Buettner,
1996). We have used the relative quanti¢cation of this radical in
the same skin sample, both before and after application of sunsc-
reen, in order to estimate the level of protection against UVA
irradiation a¡orded by three popular sunscreens that claim UVA
protection, over a range of application densities.
MATERIALS AND METHODS
Materials This study using consented skin from informed patients, was
approved by the West Hertfordshire NHS Trust (EC2002-20) and was
conducted in accordance with the Declaration of Helsinki. Caucasian skin
was obtained from consenting patients undergoing breast reduction
surgery. Skin was stored in normal-saline-soaked gauze at 41C and used
within 24 h. Prior to ESR spectroscopic analysis, skin was trimmed to
remove subcutaneous fat and cut to approximately 1 cm2. The surface area
of the skin held £at and undeformed between the silica plates of the £at cell
was measured. Sample sizes could not exceed 1 cm2 due to technical
limitations associated with tuning the spectrometer. Three popular brands
of sunscreens, which claimed UVA protection, were randomly chosen for
evaluation: brands 1, 2, and 3 were SPF 30 (containing the UVA ¢lters
titanium dioxide and terephthalylidene dicamphor sulfonic acid), SPF 25
(containing butylmethoxyldibenzoyl methane), and SPF 20þ (containing
octocrylene and titanium dioxide), respectively (¢lter concentrations were
unspeci¢ed).Two of the brands chosen had a four star UVA rating (highest
UK rating), and the third was obtained outside the UK and did not have
this rating (although it claimed UVA protection and anti-cell-aging
e¡ects). All creams were evaluated within 3 mo of purchase.
ESR experiments were carried out using a Bruker EMX spectrometer
(Rheinstetten/Karlsruhe, Germany) equipped with an ER 4103TM cavity
and a Wilmad Glass tissue cell (WG 806-B-Q) (Buena, NJ). Typical
ESR settings were 40 mW microwave power, 0.075 mT modulation
amplitude, 2105 receiver gain, and sweep time 20 s with repeated
scanning (¢ve scans) unless otherwise indicated. UV irradiation was
carried out in situ in the spectrometer (with the cavity completely shielded
by black plastic sheeting) using a super high pressure 100 W Nikon mercury
lamp (model LH-M1100CB-1) focused on the cavity transmission window.
The emission spectrum of the lamp is shown in Fig 1(a). A 5 cm water
¢lter was used to remove infrared radiation together with two optical glass
¢lters having a combined thickness of 0.7 cm Barr and Stroud ¢ltering
(available from Andover Corporation, Salem, NH) wavelengths below 300
nm and having a 1% transmittance of UVB radiation at 300 nm and 19%
at 320 nm (transmission spectrum shown in Fig 1b). Visible wavelengths
were not ¢ltered. The UV £uence incident upon the sample within the
spectrometer was measured using a potassium ferrioxalate actinometer
(Valenzeno et al, 1991), which was slightly modi¢ed as follows: 0.006 M
stock actinometer solution (0.25 mL) was irradiated (5 min) directly in the
£at cell held in the cavity of the spectrometer and then washed out of the
£at cell into a 5 mL £ask with distilled water; 2 mL of this solution was
added to 0.4 mL 1% 1,10-phenanthralene, 1 mL pH 4.5 bu¡er (Sigma), and
diluted to 5 mL with d-H2O. The optical densities of irradiated and
unirradiated solutions were compared at 510 nm. The UV £uence is within
levels of solar irradiation (the UVA component of the total UV radiation
penetrating the earth’s atmosphere is 90%) measured between 11.00 a.m.
and 3.00 p.m. with the same UV actinometer (irradiated with natural
sunlight through an aperture cut in black card to the same dimensions as
the ESR cavity window), June^September, London, UK (direct sunlight).
The photon £ux was calculated in mol quanta per second (Calvert and
Pitts, 1966, page 781, equation 7.6) and converted to radiant £ux in joules
per second by multiplying by the Avogadro constant, Planck’s constant,
and the radiation frequency at 350 nm (mean frequency 300^400 nm over
which the actinometer absorbs radiation). The molar absorptivity of
potassium ferrioxalate (1.1  103 per mol dm3 cm) is also required for this
calculation. The radiant £ux incident upon the actinometer was calculated
to be 3 mW (3 mJ per s) and the irradiance at the cavity window (area
2.3 cm2) was then calculated to be 1.3 mW per cm2 (mJ per s per cm2). The
irradiance is lower than levels of UVA that have been employed for solar-
simulated irradiation (reported levels of solar-simulated UVA are 35 and
60^80 mWper cm2) (Ley et al, 1997; Burren et al, 1998).
Adaptation and validation of the method to quantify free-radical
formation ESR methodology was used to detect the ascorbate radical
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Figure1. Irradiation. (a) Typical emission spectrum of the mercury lamp
used for irradiation experiments. Supplied with permission by the manu-
facturers (Osram). (b) Transmittance (percent of incident irradiation) mea-
sured between 250 and 820 nm of the two glass ¢lters used in irradiation
experiments.
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directly in human skin on UV irradiation as previously published
(Jurkiewicz and Buettner, 1996). The skin specimen (unprotected) was
held in a Wilmad tissue cell, placed directly into the ESR cavity, and
subjected to 100 s UV irradiation to establish the background levels of
ascorbate radical. The skin sample, when mounted in a tissue cell, was
held £at and undeformed between two silica plates comprising the tissue
cell. The UV source was then blocked and the skin area was marked
precisely on the covering silica slide and measured. The measured area is
that of the skin held £at, and undeformed, between the silica slides. The
sunscreen was applied to the measured area at a range of application levels
(quanti¢ed by weighing) centered around that recommended in the
sunscreen industry (2 mg per cm2). The slide was then placed with the
cream side directly against the skin and again UV irradiated, and the free-
radical signal intensity measured. The skin area was restricted to 0.5^1 cm2
and the amounts of cream that were applied to the skin were not lower
than 0.5 mg to minimize errors due to weighing. This set a lower limit
for application of approximately 0.5 mg per cm2. Given the results of
preliminary experiments and that the manufacturers’ recommended
application level is 2 mg per cm2, an upper limit for the quantitative
analysis of 4 mg per cm2 was chosen. Nine measurements performed in
this way were taken for each sunscreen across this range of application.
Quanti¢cation of the ascorbate radical spectrum was by measurement of
the height of the low ¢eld absorbance peak relative to the midpoint
(marked on Fig 2a). To verify that the signal of any radical species either
already present in the sunscreen or formed as a result of UV irradiation of
the sunscreen alone did not interfere with the signal of the ascorbate radical
formed in the skin, comparison with the ESR spectra obtained from
illumination of sunscreen alone was made.
Two methods were used to measure protection: (1) using the same skin
sample (reducing possible intersample variation in ascorbate levels) or (2)
comparing two di¡erent samples of the same skin both unprotected
and protected with cream. Method (1) was used for the majority of the
study, not only to reduce intersample variation of ascorbate, but also to
ensure adequate levels of ascorbate in each skin sample studied (which
occasionally could be low in some specimens, believed to be for dietary
reasons). This method required that ascorbate (1) is su⁄ciently stable in the
skin over the 100 s UV irradiation period taken to obtain a measurement,
and (2) is stable over the period between the measurements when skin was
removed from the spectrometer, coated with cream, and then reinserted in
the spectrometer. Stability over the 100 s irradiation period was veri¢ed
using fresh skin by continuous measurement of the free-radical signal
intensity over approximately 1400 s UV irradiation (Fig 2c). Stability
between measurements was also veri¢ed (not shown).
As skin was used up to 24 h post surgical excision, it was necessary
to verify that ascorbate was su⁄ciently stable with refrigerated storage
over this time period. Ascorbate levels in the skin were compared
by comparison of the ascorbate radical signal intensity upon irradiation at
di¡erent time periods of storage: at 0 (in practical terms approximately 2 h
post excision) (n¼ 3); 1 d (n¼ 9); and 3 d (n¼ 3) (Fig 2d).
To verify that the ascorbate radical signal did not originate from
irradiation scattered through the tissue cell (whose etched lower surface
decreases light transmittance considerably compared to that through the
transparent cover slip) skin was irradiated both protected at the front, and
then at the back, by black tape of similar dimensions to the skin sample.
The ascorbate radical signal was abolished when protective tape (greater
than the skin area) was between the incident irradiation and the skin, but
when the tape was placed behind the skin (to prevent entry into the skin of
scattered radiation) the ascorbate radical signal was clearly detected at a
similar signal intensity to skin not shielded by tape at the dermal aspect
(not shown). If the tape was the exact dimensions of the skin sample, and
placed in front of the skin, then a weak signal due to the ascorbate radical
could occasionally be observed (up to about 10% the unprotected signal),
suggesting entry of irradiation through the cut edge of the skin.
As a further check of the primary method used (method (1)), the
protection at 2 mg per cm2 application was also determined using method
(2) for one brand of sunscreen. Paired samples of skin were cut from the
same piece of skin (n¼ 5, separate patients) to similar dimensions. One
of these samples was mounted in the tissue cell, as described above, and
irradiated for 100 s to determine the free-radical signal intensity in
unprotected skin. This sample was then removed from the cell and
replaced by the second skin sample, which was then covered with a ¢lm
of factor 25 sunscreen applied to the upper silica slide, to an application
density of 2 mg per cm2, to an area that exceeded that of the skin sample
(to ensure blocking of the edge e¡ect). This sunscreen-protected skin was
irradiated for 100 s and the free-radical signal intensity was measured. Both
sunscreen-protected and unprotected samples, in this experiment, were
shielded at the dermal aspect with black tape. The protection provided
by a commonly used dermatologic cream, lacking UV ¢lters, was also
measured.
The dose^response of the ascorbate radical signal intensity to the UVA
irradiation was veri¢ed using neutral-density ¢lters to reduce the UVA
dose to the skin by increasing amounts. Neutral-density ¢lters were
added sequentially to the water and two glass ¢lter combination of the
UV lamp, and for each ¢lter system the absorbance at 510 nm of UV-
irradiated actinometer solution was measured, relative to unirradiated
solution. For each ¢lter system, the ascorbate radical signal intensity, upon
100 s UV irradiation, was also measured in di¡erent samples of skin, cut to
similar dimensions.
Statistics Comparison between two groups of data was undertaken
using a Student’s t test. All analyses were performed using Sigma Stat
statistics software, version 2.0 (Jandel Corporation, Chicago, IL).
RESULTS
Validation of method UV-irradiated skin produced the
recognizable ESR spectrum (Fig 2a) of the ascorbate radical
(characterized by hyper¢ne splitting a(H)¼ 0.17 mT (Jurkiewicz
and Buettner, 1996)), which was either undetectable, or detected
to very low levels, in nonirradiated skin (not shown). In contrast
0
a
sc
o
rb
at
e 
ra
di
ca
l
si
gn
al
 in
te
ns
ity
as
co
rb
at
e 
ra
di
ca
l
si
gn
al
 in
te
ns
ity
0 1  3
2
4
6
8
10
12
signal
measured
0.5 mT
light on
light off
8642 10 12 14
time (102 s)
days elapsed from excision
(a)
(b)
(c)
(d)
Figure 2. Validation of the method. (a) ESR spectra of human Cauca-
sian breast skin immediately upon irradiation. (b) Comparable irradiation
of factor 30 suncream alone (brand 1) at 2 mg per cm2 application (spectra
are centered by g-value and are directly comparable). (c) The low ¢eld ab-
sorbance peak of the ascorbate radical detected in skin immediately after
excision (marked in Fig 1a) monitored with time. The lamp iris was
opened and closed during the scan to determine the response of the radical
signal. (d) Mean ascorbate radical signal intensity at 0 d (n¼ 3), 1 d (n¼ 9),
and 3 d (n¼ 3) after excision (error bars represent standard deviations).
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to previous reports (Jurkiewicz and Buettner, 1996), the ascorbate
radical was not consistently detected in nonirradiated skin in our
experiments. This may be because the skin in our experiments
was shielded from room light, believed previously (Jurkiewicz
and Buettner) to have a small e¡ect on the radical signal, or it
may have re£ected the use in our experiments of fresh rather
than frozen skin samples (cellular degradation and metal-ion
release could have stimulated oxidative stress within these frozen
skin specimens). The radicals formed in sunscreen alone (Fig 2b
shows UV-irradiated sunscreen alone at 2 mg per cm2) did not
interfere with the ascorbate radical at application levels up to
about 4 mg per cm2; however, at applications much greater than
this (X10 mg per cm2), radical production in the sunscreen itself
becomes appreciable (brands 1 and 3).
The ascorbate radical is detected immediately in skin upon
irradiation and responds rapidly to a change in radiation levels as
shown in Fig 2(c), being restored to original levels after closing
and reopening the lamp iris. Over the whole period of UV
irradiation (up to 1400 s) the ascorbate depletion is very slight
(Fig 1c). The ascorbate radical signal decreased very slowly
with prolonged irradiation (when studied over a period of
approximately 30 min); however, the rate of decrease varied
according to the time of skin storage prior to experimentation.
Skin studied immediately after removal from the patient
exhibited very low rates of ascorbate depletion (Fig 2c)
(probably due to dehydroascorbate reductase activity in intact
viable cells that are still present in skin after 24 h refrigeration),
and UV-induced depletion rates were found to increase with
storage, becoming signi¢cant after 3 d refrigeration.
The stability of ascorbate, during refrigerated storage, was
veri¢ed by measurement of the ascorbate radical signal intensity
(upon immediate UV irradiation) in di¡erent samples of the same
piece of skin at di¡erent times of refrigerated storage (0, 1, and 3
d), as shown in Fig 2(d). The mean signal intensity is slightly
lower at 1 d after excision compared to that recorded
immediately after excision, but is broadly comparable, re£ecting
similar levels of ascorbate in the skin. At 3 d after excision, the
mean ascorbate radical signal intensity is signi¢cantly lower,
being approximately half that after excision, and thus ascorbate
levels are depleted at 3 d. Therefore, whereas every e¡ort was
made to use skin samples as soon as was practicable after
excision, a cut-o¡ period of 24 h was chosen.
Quanti¢cation of the protection provided by high factor
sunscreens Figure 3 shows ESR spectra obtained before and
after sunscreen (brand 1, factor 30) application to breast skin.
These data are typical of those used for subsequent quantitative
analysis of the protection provided by high factor sunscreens.
There was generally only a small (o50%) observable reduction
in the signal intensity of the ascorbate radical compared to
unprotected skin. This reduction appeared to peak at approxi-
mately 2 mg per cm2, with little further reduction at greater
application levels.
Figure 4(a) shows a plot of the percentage reduction in signal
intensity of the ascorbate radical (taken as the height of the low
¢eld absorption relative to the midpoint of the spectrum, Fig 2a)
at di¡erent applications of high factor sunsceens (all three brands).
The application density was calculated as the measured weight of
sunscreen applied to the upper silica slide relative to the measured
skin area of skin held £at and undeformed in the tissue cell.
The percentage reduction in signal intensity is similar for all
three brands studied and increases with application up to
approximately 2 mg per cm2 with no further protection
apparent at higher application. Despite use of skin from one
anatomic region to cut down on intersite variation, there is still
variability in the protection measured at constant application:
although this could result from unavoidable errors associated
with the experimental procedure and analysis, it could also
result from individual variations in skin architecture that a¡ect
the protection provided by the sunscreen.
A rank plot of the data in Fig 4(a) is shown in Fig 4(b): the
mean percentage reduction in signal intensity of the ascorbate
radical was calculated for levels of application 0.5^1.5, 1.5^2.5,
and 2.5^4 mg per cm2, and the standard deviation was calculated
for n¼ 3 for each sunscreen at each level of application. These
levels of application were de¢ned: the mean application of
sunscreen (for all the brands) for the 0.5^1.5 group is actually
about 1.2 mg per cm2; 2.2 mg per cm2 for the 1.5^2.5 group; and
3 mg per cm2 for the 2.5^4 mg per cm2 group. It was found that
the level of protection at each application is comparable for the
three brands studied: the protection at 1.5^2.5 mg per cm2 and
above is approximately 50%^60% reduction in signal intensity;
however, at 0.5^1.5 mg per cm2 protection is less, between 40%
and 50% for the three brands. Statistical analysis of the data
showed that for brands 1 and 2 the protection at 0.5^1.5 mg per
cm2 application is signi¢cantly lower (p¼ 0.034 and 0.024,
respectively) than the protection at 1.5^2.5 cm2. For brand 3,
although there is the same trend, this does not quite reach
statistical signi¢cance (p¼ 0.243). Data at 2.5^4.0 mg per cm2
application are not signi¢cantly di¡erent from those at 1.5^2.5
mg per cm2 (for all three brands). The di¡erences between the
protection measured at 0.5^1.5 and 1.5^2.5 mg per cm2 are
slightly lower than might be expected; however, this is believed
to re£ect the actual mean applications of 1.2 and 2.2 mg per cm2
(which are not precisely doubled). The mean application in the
2.5^4 mg per cm2 groups is actually 3 mg per cm2 and may
explain the lack of a statistically signi¢cant di¡erence between
the 2.5^4 and 1.5^2.5 mg per cm2 groups. Due to the small
sample size, interindividual variations could be contributing
here.
The ascorbate radical signal intensity is signi¢cantly lower in
sunscreen-protected skin (p¼ 0.002, 0.004, and 0.001 for brand 1
at 0.5^1.5, 1.5^2.5, and 2.5^4 mg per cm2 application, respectively,
and similar values for brands 2 and 3) compared to the control
0.5 mT
(1.3)
(2.0)
(3.6)
(10)
No cream Factor 30 cream(loading, mg/cm2)
Figure 3. Typical ESR spectra of UV-irradiated human Caucasian
skin without and with sunscreen protection. Each horizontal row is a
di¡erent skin sample unprotected (¢rst vertical column) and coated (second
vertical column) with factor 30 suncream (brand 1 with UVA protection):
applications range from 1.3 to 10 mg per cm2.
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skin, which was subjected to 100 s irradiation, removed from
the spectrometer, replaced unprotected (i.e., in the absence of
sunscreen) in the spectrometer, and re-irradiated for 100 s.
Method (2) was found to give a comparable result to the ¢rst
method of 58% (710%) reduction in signal intensity of the
ascorbate radical in sunscreen-protected skin (at 2 mg per cm2
application) relative to unprotected specimens. A dermatologic
cream, without any UV ¢lters, applied at an application density
of 2 mg per cm2 resulted in a 3.7% reduction in the ascorbate
radical signal intensity (n¼ 3). The reduction in ascorbate radical
signal intensity was found to correlate directly with the reduction
in the UV dose to the skin when irradiation was carried out
through neutral-density ¢lters (not shown). In addition, the
glass ¢lters used to ¢lter UVB wavelengths were then removed
to increase the UV dose to the skin: when the ¢lters were
removed, the signal intensity of the ascorbate radical increased,
and it was possible to lower the microwave power of the
spectrometer to observe the radical. The ascorbate radical signal
intensity therefore is not at maximum levels in the UVA system,
and this suggests that the sensitivity and usefulness of this
method is likely to improve at higher irradiation intensities than
used in our experiments.
It is concluded therefore that this ESR method is a sensitive
method for measuring free-radical protection by sunscreens and
might be used at higher UVA intensities than the irradiation
used for this study. For precise quantitative measurements, both
methods are potentially useful; however, the application of sun-
screen to a larger area than the skin (to prevent edge e¡ects)
and the protection of the skin at the dermal aspect are
recommended, particularly if the experiments are to be per-
formed at higher irradiation intensities than we have used (where
scattering of irradiation to the dermal aspect of the skin within
the ESR spectrometer might become signi¢cant). It is concluded
that the use of di¡erent skin samples, as opposed to the same
skin sample, does not signi¢cantly a¡ect the quantitative
results.
DISCUSSION
It is concluded from this study that the signal intensity of the as-
corbate radical, in UVA-irradiated skin, is directly proportional to
the UVA dose to the skin, and therefore it can be used to measure
the protection, by the reduction of the ascorbate radical signal in-
tensity, of a sunscreen applied as a barrier to the skin epidermis.
We ¢nd, using this method, that Caucasian skin is only protected
to about 55% against free-radical production by high factor
sunscreens (which provide the maximum available UVA protec-
tion in the UK), applied at the recommended application of 2 mg
per cm2, using an irradiance comparable to relatively weak solar
irradiation (within direct sunlight measurements 11.00 a.m.^3.00
p.m. June^September, London). At 0.5^1.5 mg per cm2 (actual
mean application 1.2 mg per cm2) this protection is only about
45% reduction (statistically signi¢cant) in the UV-induced radi-
cal concentrations and is likely to be less at lower applications.
The protection currently provided by sunscreens is indicated
by the erythema-based SPF measurement, i.e., the factor by
which the dose for minimal erythema (MED) is increased with
protection under standard solar-simulated conditions (or the fac-
tor by which sunlight exposure time is increased, before burning,
with sunscreen compared to without protection). The irradiation
delivered to the skin in these experiments is 1.3 mJ per cm2 per s
UVA for 100 s. One MED is about 20^30 mJ per cm2 UVB for a
Caucasian (type I skin). As UVB is 10% of the total UV compo-
nent (UVA and UVB) of sunlight penetrating the earth’s atmo-
sphere, 1 MED UVB will be associated with 180^270 mJ UVA
(which causes 0.001 of the erythemal response of UVB) (McKin-
lay and Di¡ey, 1987). The radiation used in these experiments (1.3
mJ per cm2 per s UVA) is equivalent to 130 mJ per cm2 UVA (for
100 s irradiation). Thus the UVA radiation dose in our experi-
ments is estimated to be equivalent to sunlight of MED equal to
about 0.6, i.e., to be suberythemal. It would also be of great inter-
est therefore to determine the behavior and e⁄cacy of these
sunscreens at higher UVA intensities, i.e., solar irradiation equiva-
lent to that of hotter climates; however, current limitations of
equipment have delayed this.
On the basis of the results in this study it is possible to calculate
a ‘‘free-radical protection factor’’ as the length of UVA exposure
time with sunscreen protection, compared to without protection,
to achieve the same amount of UVA penetrating the skin. As the
radical signal intensity is approximately halved at the test level of
application (2 mg per cm2), the results suggest that, using this test
method, the same UV dose will be achieved in twice the length
of duration of exposure, thus suggesting a free-radical protection
factor of about 2 (and less than 2 at typically used levels of appli-
cation). It is possible, with further development, that a free-
radical protection factor might be a useful measure of UVA pro-
tection a¡orded by sunscreens. Our results are also consistent
with previous reports (Azizi et al, 2000) that, at typical levels of
application (measured to be 0.5 mg per cm2) (Bech-Thompsen
and Wulf, 199293), the UVB protection (measured by SPF) is
less than that measured at the recommended level of application
of 2 mg per cm2. A free-radical protection factor of 2 is substan-
tially less than the erythema-based protection factors for these
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Figure 4. Quantitation of sunscreen protection at di¡erent applica-
tions. (a) Plot of the percentage reduction in ascorbate radical signal inten-
sity against application (mg per cm2) for UV-irradiated skin covered with
high factor suncreams (three brands;J, brand 1; &, brand 2; n, brand 3,
SPF 20þ and claiming UVA protection). (b) Rank plot of percentage re-
duction in ascorbate radical signal intensity (n¼ 3 for each brand at each
level of application) for UV-irradiated skin covered with high factor sun-
creams (open, hashed and shaded bars, brands 1, 2, and 3, respectively) at dif-
ferent levels of application (0.5^1.5, 1.5^2.5, and 2.5^4 mg per cm2). Error
bars represent standard deviations, and the protection at 0.5^1.5 cm2 appli-
cation (brands 1 and 2) is signi¢cantly lower (p¼ 0.034 and 0.024) than the
protection at 1.5^2.5 cm2 application. The ascorbate radical signal intensity,
in sunscreen-protected skin, is signi¢cantly lower (p¼ 0.002, 0.004, and
0.001 for brand 1 at 0.5^1.5, 1.5^2.5, and 2.5^4 mg per cm2 application, re-
spectively, and similar values for brands 2 and 3) compared to untreated
skin.
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creams (20^30) and suggests that users of these creams will be
disproportionately exposed to UVA.
Although there are published methodologies to measure UVA
protection (reviewed by Lim, 2001), these have yet to be applied
to directly quantify the protection provided by sunscreens that
are currently commercially available. These sunscreens (available
in Europe) often do not provide data for the percentage compo-
sition of ¢lters they contain. A study to develop a methodology
to quantify UVA protection in commercial creams (Takeuchi
et al, 1998) suggests that a UVA protection of 2 is a¡orded by a
factor 15 UVA sunscreen, compared to a protection factor of 3
by a UVA ¢lter (3% butylmethoxydibenzoyl methane) in a base
cream (using transgenic mice containing the human elastin pro-
moter linked to a chloramphenicol acetyl transferase reporter
gene). These results, although obtained using a lower SPF rated
sunscreen, and mouse rather than human skin, are broadly com-
parable to our results. Ley and Fourtanier (1997) measured the
protection against UVA-induced DNA damage in mouse skin
a¡orded by a UVA ¢lter in a base cream: using a 5% ¢lter
(terephthalylidene dicamphor sulfonic acid) they found an 8-fold
reduction in DNA damage; however, the sunscreen preparation
may have included a higher percentage of ¢lter than that used
in commercial preparations. It is also interesting that a sun-
screen formulation providing low UVA protection provided 57%
protection against UVAI immunosuppression (Dumay et al,
2001).
As our irradiation source contains visible light, it is possible
that the protection against free-radical production is low because
of a visible light contribution to damage; however, the results
of Jurkiewicz and Buettner (1996) suggest that the visible light
contribution is minor compared to that of UVA, and the former’s
contribution may re£ect a tail of the UVA chromophore
(unidenti¢ed), which extends into the blue-visible region of the
spectrum, rather than a separate visible chromophore. The
importance of the visible light contribution is a separate subject
worthy of further investigation, as sunscreens are not designed to
extend beyond the UV region of the solar spectrum.
In conclusion, the results of this study to investigate free-radi-
cal protection by certain currently available high factor sunscreens
suggest they provide approximately 55% protection when ap-
plied directly to the skin at the recommended amount of 2 mg
per cm2, and less at lower application (at an irradiance comparable
to solar UVA). The use of ESR to measure directly the UVA-in-
duced free-radical production in human skin is a rapid and useful
method to measure the free-radical/UVA protection. The results
suggest that sunscreen users are little protected against UVA
free-radical production and the damaging e¡ects of UVA. In par-
ticular, as the existing sunscreen SPF provides a measure of the
protection principally against UVB-induced erythema, users of
high factor sunscreens may have an arti¢cial sense of security that
they are protected similarly against UVA. Thus, as already sug-
gested by Autier et al (1995), use of high factor sunscreens may
paradoxically be associated with increased skin cancer risk. The
role of UVA in melanoma development, however, and the role
of sunscreens in protecting against skin cancer, is still inconclu-
sive and controversial (Urbach, 199293) and further work will
be necessary to clarify these issues.
There is therefore an urgent need for clari¢cation of the role of
UVA in skin malignancy; for the validation of UVA SPF mea-
surements of commercial sunscreens; for the UVA protection to
be reassessed by sunscreen manufacturers to re£ect the protection
at typical levels of application; and also for the production of
more e¡ective UVA sunscreens at these levels of application.
Our results suggest that the UVA/free-radical protection cur-
rently provided by sunscreens is inadequate, and it may be a pre-
cautionary measure that Caucasians (especially those with fairer
skin types and at higher risk of skin cancer) avoid prolonged
sunbathing, even though ‘‘protected’’ by sunscreens, as the use of
sunscreens could increase their risk of UVA-induced free-radical
damage.
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